Clinical Trials on Herpes Simplex, Genital

Total 277866 results

Beijing Center for Disease Control and Prevention

Unknown

The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

Varicella

China
Yonsei University

Unknown

Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

Herpes Zoster | CRPS

Korea, Republic of
National Center for Complementary and Integrative...

Completed

Tai Chi Chih and Varicella Zoster Immunity

Varicella

United States
TWi Biotechnology, Inc.

Recruiting

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

Generalized Epidermolysis Bullosa Simplex

United States, Taiwan, Australia, Philippines
Louis Stokes VA Medical Center
Duke University

Unknown

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Shingles
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

An Immunity Persistence Study of Live Attenuated Varicella Vaccine

Varicella

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Varicella

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age

Varicella

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Varicella

China
Curevo Inc
Green Cross Corporation; IDRI; Mogam Biotechnology Research Institute

Completed

Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects

Herpes Zoster | Varicella Zoster

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Varicella-Zoster Vaccination and Infection

Herpes Zoster | Chickenpox

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Second Dose of Biken's Varicella Vaccine

Varicella

Argentina
CHA Vaccine Institute Co., Ltd.

Recruiting

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

Herpes Zoster | Vaccine-Preventable Diseases

Korea, Republic of
University Health Network, Toronto

Completed

Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients

Varicella Zoster Vaccine

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

Herpes Virus-Related Illnesses

United States, Uganda
Population Council
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Ministry of Health, Thailand and other collaborators

Completed

Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

HIV Infections | Herpes Simplex | Syphilis | Trichomonas Vaginitis | Chlamydia Trachomatis | Neisseria Gonorrhoeae

Thailand
Northwestern University

Active, not recruiting

Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection

Forehead Rhytid Complex | Glabellar Rhytid Complex

United States
University of Washington
National Institute on Aging (NIA)

Recruiting

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

Varicella Zoster Virus Infection

United States
Deepali Kumar

Unknown

Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Varicella Zoster Vaccine

Canada
Cangene Corporation

Approved for marketing

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

Varicella
University of Zurich

Withdrawn

Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study

Herpes Zoster
Beijing Center for Disease Control and Prevention

Completed

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

Chickenpox | Zoster

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Varicella

Philippines
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Herpes Zoster

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

Varicella

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Active, not recruiting

Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province

Varicella

China
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).

Varicella

Australia
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine

Varicella
GlaxoSmithKline

Completed

Study of Two Formulations of GSK Biologicals' Varicella Vaccine

Varicella

Czechia, Hungary
Pascoe Pharmazeutische Praeparate GmbH
Dr. Loges & Co. GmbH

Completed

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles (168)

Virus Diseases | Herpes Zoster

Germany
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

Varicella

China
Seoul National University Hospital

Completed

Optimal Timing of Zoster Vaccine After Zoster Illness

Shingles

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Herpes Zoster
GlaxoSmithKline

Completed

Evaluation Of Valaciclovir In Patients With Chickenpox

Varicella
Changchun Keygen Biological Products Co., Ltd.
Guangdong Provincial Institute of Biological Products And Materia Medica

Completed

Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine

Varicella

China
Beijing Center for Disease Control and Prevention

Unknown

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

Varicella

China
Cairo University

Not yet recruiting

Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

Lichen Simplex Chronicus

Egypt
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Adult AIDS Clinical Trials Group

Completed

Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy

HIV Infections | Herpes Zoster

United States
Merck Sharp & Dohme LLC
Kaiser Permanente

Completed

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Herpes Zoster | Shingles
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Hospital Colorado; Children's Hospital Medical Center, Cincinnati

Not yet recruiting

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Varicella Zoster

United States
GlaxoSmithKline

Completed

A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

Herpes Zoster

United States, Australia, Germany, Spain, Japan, Taiwan, Sweden, Korea, Republic of, Hong Kong, Mexico, Canada, France, Italy, Brazil, Estonia, United Kingdom, Czechia, Finland
University of Sao Paulo
University of Sao Paulo General Hospital

Unknown

RCT :Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb

Complex Regional Pain Syndrome I of Upper Limb

Brazil
University of Colorado, Denver
Centers for Disease Control and Prevention

Withdrawn

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

Persistence of Varicella Immunity

United States
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Cooperative Clinical Trials in Pediatric Transplantation and other collaborators

Terminated

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Kidney Transplant Recipients

United States
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

Herpes Zoster
The Hospital for Sick Children

Completed

The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation

Organ Transplantation | Immunosuppression

Canada
The University of Hong Kong

Completed

VZV Vaccine for Hematopoietic Stem Cell Transplantation (VZIDST)

Varicella Zoster Infection

Hong Kong
Baylor College of Medicine

Completed

Valacyclovir in Immunocompromised Children

Bone Marrow Transplantation | Shingles

United States

Clinical Trials on Herpes Simplex, Genital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations